Whitespace beyond conventional expert search.
A gene editing company used Urchin to ask whether valuable opportunities were still hiding outside the boundaries of its own expert search.
200+CandidatesEvaluated across biology, genetics, landscape and feasibility.
11AnalysesDeveloped in full from the candidate set.
6ShortlistElevated to the primary shortlist.
3RoundsOf refinement with the scientific team.
Source: engagement recordA gene editing company
Project overview
Context
A gene editing company was exploring how to deploy a novel therapeutic modality across a broad disease landscape. The team had already spent years thinking deeply about the opportunity space and had developed a strong intuition for where the field was likely to go. The question was not whether promising opportunities existed. It was whether there were still valuable opportunities hiding outside the boundaries of conventional expert search.
The challenge
Emerging therapeutic modalities tend to converge rapidly on the same handful of diseases, targets, and development strategies. Teams draw from the same literature, the same conferences, and the same set of visible success stories, creating a strong pull toward consensus programs. The challenge was to creatively expand the search space itself before systematically exploring it.
What Urchin did
- Evaluated 200+ candidate opportunities across disease biology, human genetics, competitive landscape, delivery feasibility, clinical tractability, and strategic differentiation.
- Iteratively refined the search over 3 rounds based on feedback from the scientific team.
- Developed 11 opportunities into full analyses, elevating 6 to a primary shortlist spanning multiple therapeutic categories and development strategies.
- Generated structured reasoning traces and deep-dive analyses for shortlisted opportunities to support downstream prioritization and decision-making.
A breadth-first exploration of the therapeutic opportunity landscape, combining biological reasoning with translational and commercial considerations.
Impact
Several of the highest-priority opportunities surfaced by Urchin were described by the project's scientific lead as candidates that he would not have identified independently, despite having spent years thinking about this therapeutic space. One example was a therapeutic strategy whose value came specifically from being permanent: a mechanism where irreversibility was not a liability but the primary advantage.
As the engagement progressed, new opportunities increasingly clustered around previously identified biological themes, which suggested the landscape had become substantially mapped.